KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Repurchased
Ratios

Charles River Laboratories International (CRL) Long-Term Debt Issuances (2016 - 2025)

Historic Long-Term Debt Issuances for Charles River Laboratories International (CRL) over the last 16 years, with Q3 2025 value amounting to $107.5 million.

  • Charles River Laboratories International's Long-Term Debt Issuances fell 5436.94% to $107.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 billion, marking a year-over-year decrease of 1721.31%. This contributed to the annual value of $1.1 billion for FY2024, which is 3931.56% up from last year.
  • As of Q3 2025, Charles River Laboratories International's Long-Term Debt Issuances stood at $107.5 million, which was down 5436.94% from $547.0 million recorded in Q2 2025.
  • Over the past 5 years, Charles River Laboratories International's Long-Term Debt Issuances peaked at $3.0 billion during Q2 2021, and registered a low of $51.2 million during Q3 2023.
  • Its 5-year average for Long-Term Debt Issuances is $675.4 million, with a median of $440.3 million in 2024.
  • Its Long-Term Debt Issuances has fluctuated over the past 5 years, first surged by 11197280000.0% in 2021, then plummeted by 9267.17% in 2023.
  • Quarter analysis of 5 years shows Charles River Laboratories International's Long-Term Debt Issuances stood at $831.4 million in 2021, then crashed by 81.51% to $153.8 million in 2022, then surged by 188.31% to $443.3 million in 2023, then crashed by 76.36% to $104.8 million in 2024, then grew by 2.58% to $107.5 million in 2025.
  • Its last three reported values are $107.5 million in Q3 2025, $547.0 million for Q2 2025, and $416.3 million during Q1 2025.